Results 101 to 110 of about 60,915 (280)

Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization

Transplant Infectious Disease, EarlyView.
Rare instances occur in which discriminatory NAT results cannot be resolved in deceased organ donor cases. When these events occur the impact on organ donation can be substantial. ABSTRACT Background Nucleic acid testing (NAT) is essential for detecting transmissible viral infections in deceased organ donors and guiding safe organ allocation.
Sara Dionne, Hillary Akana, Kaitlin Logue, Brenden O'Neale, Chris Curran, Sean VanSlyck   +5 more
wiley   +1 more source

Residual risk of human immunodeficiency virus, hepatitis C, and hepatitis B following implementation of sexual risk behavior‐based screening in Canada

Transfusion, EarlyView.
Abstract Background In 2022, Canadian Blood Services implemented a gender‐neutral sexual behavior‐based screening (SBBS) approach to donor deferral, replacing time‐based criteria targeting gay, bisexual and other men who have sex with men (gbMSM) and female partners of gbMSM. We assessed the impact of this policy change on human immunodeficiency virus (
Chinchin Wang, Steven J. Drews, Mindy Goldman, Sheila F. O'Brien   +3 more
wiley   +1 more source

Localized Gastrointestinal Light Chain (AL) Amyloidosis Under Surveillance for Five Years: A Case Report

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Amyloidosis, characterized by the deposition of abnormal protein fibrils in organs, is classified as systemic or localized. Amyloid light chain (AL)‐type localized amyloidosis is uncommon, particularly when confined to the gastrointestinal tract.
Shunsuke Kojimahara, Keiichi Tominaga, Akira Yamamiya, Mimari Kanazawa, Takanao Tanaka, Takeshi Sugaya, Nagaaki Katoh, Atsushi Irisawa   +7 more
wiley   +1 more source

HBsAg Quantification in Clinical Practice [PDF]

Journal of Clinical and Experimental Hepatology, 2012
Several standardized commercial assays for quantification of hepatitis B surface antigen (qHBsAg) are now available. Studies on HBsAg kinetics from Asia and Europe have demonstrated that HBsAg levels are highest during the immune-tolerant phase, become lower during immune-clearance phase and are the lowest in hepatitis B 'e' antigen (HBeAg)-negative ...
openaire   +2 more sources

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu, Margarita Papatheodoridi, Habiba Kamal Khodir, Sabela Lens, Elisabetta Degasperi, Speranta Iacob, Liliana Gheorghe, Katja Steppich, Florin Alexandru Caruntu, Pietro Lampertico, Soo Aleman, Heiner Wedemeyer   +11 more
wiley   +1 more source

To the problem of extended serological testing for viral hepatitis B in rheumatoid arthritis patients

Терапевтический архив
Aim. The objectives of the study: to conduct serologic screening for latent HBV infection in rheumatoid arthritis (RA) patients, to determine the level of protective antibodies to HBsAg in RA patients, and to determine the clinical and laboratory ...
Galina I. Gridneva, Boris S. Belov, Zhanna G. Verizhnikova, Evgeniia S. Aronova, Elena Yu. Samarkina, Taras S. Panevin, Tatiana A. Lisitsyna, Galina V. Lukina   +7 more
doaj   +1 more source

Chronic hepatitis in end-stage renal disease: Comparison of HBsAg-negative and HBsAg-positive patients

, 1985
Chronic hepatitis in end-stage renal disease: Comparison of HBsAg-negative and HBsAg-positive patients. To determine the outcome of chronic hepatitis in ESRD we studied all 358 renal transplant recipients and 295 hemodialysis patients treated for > 1 ...
Kenick, Scott, Parfrey, Patrick S., Farge, Dominque, Guttmann, Ronald D., Clarke Forbes, R.D., Dandavino, Raymond   +5 more
core   +1 more source

First Reported Case of Fulminant Weil's Disease in South Khorasan, Eastern Iran: Diagnostic Challenges in a Non‐Endemic Region and Implications for Military Deployment

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Weil's disease should be considered even in non‐endemic regions when compatible clinical findings are accompanied by relevant exposure history. This case is epidemiologically notable as the first documented report from South Khorasan Province, highlighting the diagnostic challenges of leptospirosis in non‐endemic settings and the potential ...
Zohreh Azarkar, Anahita Arian, Motahareh Mahi‐Birjand, Parvin Askari   +3 more
wiley   +1 more source

Erişkin HBsAg Pozitif Hastalarda Hepatit A Seroprevalansı

Genel Tıp Dergisi, 2020
Amaç: Hepatit A virüs HAV nadiren fulminan hepatite neden olmakla beraber, özellikle viral hepatit kronik karaciğer hastalığı olan kişilerde görülebilen HAV ko-enfeksiyonu daha ciddi klinik tablolara neden olabilir.
Alper Tahmaz, Süleyman Sırrı Kılıç, Özgür Günal, Sevil Alkan Çeviker   +3 more
doaj  

Chronic Spontaneous Coronary Artery Dissection in a Young Woman Managed With Coronary Artery Bypass Grafting: A Case Report With Literature Review

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Spontaneous coronary artery dissection (SCAD) is an uncommon, non‐atherosclerotic cause of acute coronary syndrome, typically occurring in young to middle‐aged women. Although most cases resolve spontaneously with conservative therapy, a small proportion develop chronic dissections that require revascularization.
Gashaw Solela, Desalew Mekonnen, Nish Patel, Jim Kauten, Chala Fekadu Oljira, Adane Petros, Siraj Kemal Mussa, Gashayeneh Genetu Tiruneh, Getu Kusa Wakoya, Tesfamariam Aklilu Betemariam, Dagmawit Mesfin Tasew, Clifford J. Kavinsky, Tesfaye Telila, Obsinet Merid   +13 more
wiley   +1 more source